The use of preliminary scientific evidence in public health: a case study of XMRV.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 24714396.
- Also identified by DOI 10.1371/journal.pmed.1001623 and PMC identifier 3979645.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Kumanan Wilson and colleagues explain how the rapid response to XMRV as a novel pathogen has highlighted some challenges pertaining to policy-making and editorial responsibilities. The impact on policy and the propagation of the initial scientific information may not cease if the evidence is disproven and retracted from the peer-reviewed literature, which creates a challenge for regulators and scientific journals. Please see later in the article for the Editors' Summary.
Medical subject headings
- Editorial Policies
- Health Policy
- Policy Making
- Public Health
- Retroviridae Infections
- Xenotropic murine leukemia virus-related virus